Novel coronavirus infection and Kawasaki disease.
J Matern Fetal Neonatal Med
; 35(16): 3044-3048, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-1908605
ABSTRACT
There is a global problem of increment of the number of children with clinical features that mimic Kawasaki Disease (KD) during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The disease was first reported by Tomisaku Kawasaki, a Japanese pediatrician, in a four-year-old child with a rash and fever at the Red Cross Hospital in Tokyo in January 1961. Now Kawasaki disease is recognized worldwide. The complexity of symptoms was defined as an «acute febrile mucocutaneous lymphnode syndrome". At the moment, it is still unclear whether the coronavirus itself can lead to development of mucocutaneous lymph node syndrome. However, it is believed that COVID-19 virus infection worsens the course of Kawasaki disease, and in some cases, children affected by SARS-V-2 may develop a disease that has a clinical picture similar to Kawasaki disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Mucocutaneous Lymph Node Syndrome
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Child
/
Child, preschool
/
Humans
Language:
English
Journal:
J Matern Fetal Neonatal Med
Journal subject:
Obstetrics
/
Perinatology
Year:
2022
Document Type:
Article
Affiliation country:
14767058.2020.1800633
Similar
MEDLINE
...
LILACS
LIS